UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 720 - 728
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Incidence | Neoplasms - drug therapy | Venous Thromboembolism - etiology | Neoplasms - complications | Venous Thromboembolism - prevention & control | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Factor Xa Inhibitors - adverse effects | Intention to Treat Analysis | Aged, 80 and over | Adult | Female | Aged | Hemorrhage - chemically induced | Rivaroxaban - therapeutic use | Prevention | Rivaroxaban | Cancer patients | Usage | Safety and security measures | Thromboembolism | Health aspects | Risk factors | Intervention | Statistical analysis | Oncology | Thrombosis | Patients | Lymphoma | Bleeding | Embolism | Disease prevention | Ultrasonic imaging | Health risk assessment | Cancer | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 17, pp. 2189 - 2204
Life Sciences & Biomedicine | Oncology | Science & Technology | Cardiology. Vascular system | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Blood and lymphatic vessels | Tumors | Venous Thromboembolism - prevention & control | Neoplasms - blood | Risk Assessment | United States | Humans | Venous Thromboembolism - therapy | Venous Thromboembolism - drug therapy | Practice Guidelines as Topic | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2007, Volume 25, Issue 21, pp. 3158 - 3167
Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Biological and medical sciences | Medical sciences | Tumors | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Drug Administration Schedule | Follow-Up Studies | Risk Assessment | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasms - mortality | Male | Treatment Outcome | Fever - chemically induced | Cause of Death | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Dose-Response Relationship, Drug | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neutropenia - prevention & control | Primary Prevention - methods | Survival Analysis | Adult | Female | Fever - prevention & control | Neoplasms - pathology | Neutropenia - chemically induced | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2009, Volume 27, Issue 29, pp. 4902 - 4911
Life Sciences & Biomedicine | Oncology | Science & Technology | Venous Thromboembolism - mortality | Prognosis | Drug Administration Schedule | Risk Assessment | Humans | Neoplasms - mortality | Anticoagulants - therapeutic use | Male | Treatment Outcome | Evidence-Based Medicine | Heparin, Low-Molecular-Weight - therapeutic use | Cause of Death | Venous Thromboembolism - drug therapy | Randomized Controlled Trials as Topic | Venous Thromboembolism - etiology | Dose-Response Relationship, Drug | Neoplasms - complications | Venous Thromboembolism - prevention & control | Primary Prevention - methods | Survival Analysis | Female | Index Medicus | Psc5 | Review | Psc12 | To7
Journal Article
Cancer investigation, ISSN 0735-7907, 09/2019, Volume 37, Issue 8, pp. 325 - 326
Journal Article
The Lancet (British edition), ISSN 0140-6736, 10/2020, Volume 396, Issue 10257, pp. 1067 - 1068
COVID-19 | Coronavirus Infections | SARS-CoV-2 | Pandemics | Humans | Betacoronavirus | Pneumonia, Viral | Neoplasms | Cohort Studies | Medical research | Autopsies | Hematology | Laboratories | Mortality | Severe acute respiratory syndrome | Oncology | Malignancy | Coronaviruses | Medical screening | Severe acute respiratory syndrome coronavirus 2 | Genetics | Diagnostic systems | Cancer | Vital statistics | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 10, pp. 1134 - 1150
Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | Humans | Antineoplastic Agents - therapeutic use | Receptors, Estrogen - analysis | Carcinoma, Ductal, Breast - mortality | Carcinoma, Ductal, Breast - chemistry | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Urokinase-Type Plasminogen Activator - analysis | Antineoplastic Agents, Hormonal - therapeutic use | Carcinoma, Ductal, Breast - pathology | Female | Chemotherapy, Adjuvant | Reproducibility of Results | Biomarkers, Tumor - analysis | Comorbidity | Clinical Decision-Making - methods | Evidence-Based Medicine | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Plasminogen Activator Inhibitor 1 - analysis | Disease-Free Survival | Breast Neoplasms - pathology | Survival Analysis | Breast Neoplasms - mortality | Receptor, ErbB-2 - analysis | Neoplasm Staging | Index Medicus | Bc2 | Bc1 | Bc6 | Bc5 | Gdln1 | To2 | Bc7 | ASCO Special
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 10, pp. 1134 - 1150
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 794 - 810
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Biological and medical sciences | Medical sciences | Tumors | Bacterial Infections - drug therapy | Humans | Antibiotic Prophylaxis - methods | Mycoses - microbiology | Treatment Outcome | Fever - chemically induced | Neutropenia - drug therapy | Antifungal Agents - therapeutic use | Neoplasms - drug therapy | Anti-Bacterial Agents - therapeutic use | Outpatients | Antineoplastic Agents - adverse effects | Review Literature as Topic | Bacterial Infections - chemically induced | Mycoses - drug therapy | Adult | Neutropenia - chemically induced | Fever - drug therapy | Bacterial Infections - microbiology | Mycoses - chemically induced | Practice Guidelines as Topic | Index Medicus
Journal Article
10.
Full Text
Development and validation of a predictive model for chemotherapy- associated thrombosis
Blood, ISSN 0006-4971, 05/2008, Volume 111, Issue 10, pp. 4902 - 4907
Life Sciences & Biomedicine | Hematology | Science & Technology | Predictive Value of Tests | Thrombosis - chemically induced | Risk Assessment | Humans | Middle Aged | Logistic Models | Male | Neoplasms - complications | Antineoplastic Agents - adverse effects | Models, Biological | Diagnosis, Computer-Assisted - methods | Female | Aged | Cohort Studies | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article